Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Alleva

Carl J. Alleva, Simsbury, CT US

Patent application numberDescriptionPublished
20090184522PERMANENT MAGNET ALTERNATOR SPEED DETECTION CIRCUIT WITH FEEDBACK AT LOWER SPEEDS - A permanent magnet alternator is driven by a turbine engine to supply three phases of power to a control circuit for the engine. A shunt regulator delivers current to the control circuit, and a voltage supply is also included to deliver power for a period of time as the alternator is gaining speed at startup. A speed detection circuit detects the speed of the shaft for diagnostic purposes and a feedback circuit overrides a control for the supply of the current at lower speeds such that the speed detection circuit will be accurate even at lower speeds.07-23-2009

David Alleva, San Diego, CA US

Patent application numberDescriptionPublished
20080292640METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES - Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.11-27-2008
20100303807METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES - Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.12-02-2010
20110038859METHODS FOR THE TREATMENT OF IL-1BETA RELATED DISEASES - Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.02-17-2011

Patent applications by David Alleva, San Diego, CA US

Fileno A. Alleva, Redmond, WA US